Posts in category: Uncategorized

A beating heart makes for a formidable surgical arena, but a new robotic catheter could someday equip surgeons to operate in the cardiac environment with greater ease.

Elite esports gamers contend with pressures that significantly impact their performance, as revealed in a recent study conducted by the University of Chichester.

The prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in the United States in 2021 to 2022 was 1.3 percent, according to a December data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

A new study has found that the Protecting Life in Global Health Assistance policy, formerly known as the Mexico City Policy, reduced the provision and use of contraceptives, as well as community health volunteer services, in African countries.

Can AI save us from the arduous and time-consuming task of academic research collection? An international team of researchers investigated the credibility and efficiency of generative AI as an information-gathering tool in the medical field.

Cocaine use is becoming normalized in parts of party culture, according to a new study of Roskilde festival attendees. It also shows that cannabis is now widely accepted and not even considered a “drug” by many young people.

The Food and Drug Administration announced last week that it’s investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care over the past decade. The treatment reprograms a patient’s T cells, a key part of the immune system, to recognize and attack cancer cells.

Systemic lupus erythematosus (SLE) is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical practice must change accordingly, to keep up with modern treatment options and to make the most of new drugs that can target key pathophysiological pathways. In line with this, EULAR has updated its recommendations for managing SLE.

Fatigue is common in people with inflammatory rheumatic and musculoskeletal diseases (RMD). The causes of fatigue are not well understood, and it is likely that they vary between people and over time. From a patient perspective, fatigue has a significant and detrimental impact on daily life, and it is a priority to address.

By NATION REPORTER

GOVERNMENT has announced that current statistics show that maternal mortality is at 278/100, 000 live births and neonatal mortality is 27/1, 000 live births.